Download full announcement Further to the announcement on 20 December 2018, Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the appointment of Stifel... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility... read more →
Company Adds Clinical and Data Security Expertise to Support KidneyIntelX Clinical Validation, Software and Regulatory Programmes Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics... read more →
Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigators Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled... read more →
Download full announcement This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence ("AI") enabled clinical diagnostics solutions for kidney disease, announces the exercise of its option, as described in... read more →
Download full announcement The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each (“Ordinary Shares”) in the Company... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence (“AI”) enabled clinical diagnostics solutions for kidney disease, notes the announcement today by EKF Diagnostics Holdings plc... read more →
Download full announcement The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each (“Ordinary Shares”) in the Company... read more →
Download full announcement NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or... read more →